Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
American Thyroid Association
6066 Leesburg Pike Suite 550Falls Church, Virginia, United States
Email Phone Web
The American Thyroid Association® (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. The ATA delivers its mission of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health.
Their goals include:
• To foster and support research on thyroid molecular and cell biology, physiology, and diseases.
• To disseminate new knowledge that leads to prevention, diagnosis,and treatment of thyroid diseases.
• To support education of trainees, basic scientists, physicians, and other health care professionals concerned with investigating, diagnosing, and treating thyroid diseases.
• To establish and guide public policies on the causes, diagnosis, and management of thyroid diseases and related disorders.
• To be the advocate for thyroid specialists in the councils concerned with science, clinical medicine, and health care delivery.
• To encourage broad-based support from industry and other parties to fulfill the Association’s scientific and educational missions.
• To stimulate philanthropic giving to a fund that supports the Association’s activities.
myBinderRelated Content
-
Teprotumumab Improves Short and Long-Term Clinical Outcomes in Thyroid Eye DiseaseMost adults with thyroid eye disease rec...
-
FDA Committee Unanimously Recommends Approval of Teprotumumab for Thyroid Eye DiseaseThe Dermatologic and Ophthalmic Drugs Ad...
-
Early Diagnosis of Thyroid Eye Disease (TED)Early Symptoms TED can first present wi...
-
Surgical Management of Graves’ – Dr. Kevin Brumundhttps://www.youtube.com/watch?v=0BfIbnrv...
-
Kenneth D. Burman, MDKenneth D. Burman is the Chief of Endocr...
-
Enfermedad de Grave’s FAQ¿Qué es la enfermedad de Grave’s? L...
-
New Data from Phase 3 Teprotumumab Trial Shows Dramatic Reduction in Proptosis, or Eye Bulging, the Main Cause of Mo...Horizon Pharma plc today announced that ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Google